Vaccine manufacturing sites

José Luis Zafra a fait une demande de Accès à l'information à Agence européenne des médicaments

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

La réponse à cette demande est très en retard Agence européenne des médicaments aurait déjà dû répondre à la demande (détails). Vous pouvez vous plaindre en Solliciter une révision interne .

José Luis Zafra

Dear European Medicines Agency,

Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information:

During the last week of April (day 26th to 30th), the European Immunization Week campaing promoted official EU accounts to share facts and data about vaccines in the continent. One of the shared contents ( by the European Commision was a map reflecting the vaccine manufacturing sites across the Union.

My request is if there's a list of these vaccine manufacturing sites, the city where they are located and the name of the factory and/or company that it's in charge of these sites.

Yours faithfully,

José Luis Zafra

Agence européenne des médicaments

2 Attachments

Delivery has failed to these recipients or groups:

[1]documents requests at EMA ([EMA request email])
The email address you entered couldn't be found. Please check the
recipient's email address and try to resend the message. If the problem
continues, please contact your helpdesk.

Diagnostic information for administrators:

Generating server:

[EMA request email]
Remote Server returned '550 5.1.1 RESOLVER.ADR.RecipNotFound; not found'

Original message headers:

Received: from ( by
( with Microsoft SMTP Server (TLS) id 15.0.1497.2; Mon, 10 May
2021 10:22:31 +0200
Received: from ( by ( with Microsoft SMTP Server (TLS) id
15.0.1497.2 via Frontend Transport; Mon, 10 May 2021 10:22:31 +0200
Return-Path: <[FOI #9459 email]>
Received: from [] (using TLSv1.2 with cipher DHE-RSA-AES256-GCM-SHA384 (256 bits))
by id B3/CF-53303-74DE8906; Mon, 10 May 2021 08:22:31 +0000
Authentication-Results:; spf=pass
( domain of designates as permitted sender); dkim=none
(message not signed); dmarc=none (no record)
X-Brightmail-Tracker: H4sIAAAAAAAAA+NgFmpkkeJIrShJLcpLzFFi42LR01bP0XV7OyP
X-Env-Sender: [FOI #9459 email]
X-Originating-IP: []
X-SpamReason: No, hits=0.0 required=7.0 tests=newsletters:
X-StarScan-Version: 9.75.3; banners=-,-,-
X-VirusChecked: Checked
Received: (qmail 18985 invoked from network); 10 May 2021 08:22:30 -0000
Received: from (HELO (
by with ECDHE-RSA-AES256-GCM-SHA384 encrypted SMTP; 10 May 2021 08:22:30 -0000
Received: from foieu by with local (Exim 4.89)
(envelope-from <[FOI #9459 email]>)
id 1lg1BO-0002mq-4w
for [EMA request email]; Mon, 10 May 2021 09:22:30 +0100
Date: Mon, 10 May 2021 09:22:30 +0100
From: =?UTF-8?B?Sm9zw6kgTHVpcyBaYWZyYQ==?=
<[FOI #9459 email]>
To: documents requests at EMA <[EMA request email]>
Message-ID: <[email address]>
Subject: access to documents request - Vaccine manufacturing sites
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable


Visible links
1. mailto:[EMA request email]